Anjan Motamarry1,2, Ayele H Negussie3, Christian Rossmann2, James Small4, A Marissa Wolfe5, Bradford J Wood3, Dieter Haemmerich2,6. 1. Department of Drug Discovery & Biomedical Sciences, Medical University of South Carolina , Charleston , SC , USA. 2. Department of Pediatrics, Medical University of South Carolina , Charleston , SC , USA. 3. Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health , Bethesda , MD , USA. 4. Department of Public Health Sciences, Medical University of South Carolina , Charleston , SC , USA. 5. Department of Comparative Medicine, Medical University of South Carolina , Charleston , SC , USA. 6. Department of Bioengineering, Clemson University , Clemson , SC , USA.
Abstract
Objective: Thermosensitive liposomal doxorubicin (TSL-Dox) is a promising stimuli-responsive nanoparticle drug delivery system that rapidly releases the contained drug in response to hyperthermia (HT) (>40 °C). Combined with localized heating, TSL-Dox allows highly localized delivery. The goals of this study were to demonstrate that real-time fluorescence imaging can visualize drug uptake during delivery, and can predict tumor drug uptake. Methods: Nude mice carrying subcutaneous tumors (Lewis lung carcinoma) were anesthetized and injected with TSL-Dox (5 mg/kg dose). Localized HT was induced by heating tumors for 15, 30 or 60 min via a custom-designed HT probe placed superficially at the tumor location. In vivo fluorescence imaging (excitation 523 nm, emission 610 nm) was performed before, during, and for 5 min following HT. After imaging, tumors were extracted, drug uptake was quantified by high-performance liquid chromatography, and correlated with in vivo fluorescence. Plasma samples were obtained before and after HT to measure TSL-Dox pharmacokinetics. Results: Local drug uptake could be visualized in real-time during HT. Compared to unheated control tumors, fluorescence of heated tumors increased by 4.6-fold (15 min HT), 9.3-fold (30 min HT), and 13.2-fold (60 min HT). HT duration predicted tumor drug uptake (p = .02), with tumor drug concentrations of 4.2 ± 1.3 µg/g (no HT), 7.1 ± 5.9 µg/g (15 min HT), 14.1 ± 6.7 µg/g (30 min HT) and 21.4 ± 12.6 µg/g (60 min HT). There was good correlation (R2 = 0.67) between fluorescence of the tumor region and tumor drug uptake. Conclusions: Real-time in vivo fluorescence imaging can visualize drug uptake during delivery, and can predict tumor drug uptake.
Objective: Thermosensitive liposomal doxorubicin (TSL-Dox) is a promising stimuli-responsive nanoparticle drug delivery system that rapidly releases the contained drug in response to hyperthermia (HT) (>40 °C). Combined with localized heating, TSL-Dox allows highly localized delivery. The goals of this study were to demonstrate that real-time fluorescence imaging can visualize drug uptake during delivery, and can predict tumor drug uptake. Methods:Nude mice carrying subcutaneous tumors (Lewis lung carcinoma) were anesthetized and injected with TSL-Dox (5 mg/kg dose). Localized HT was induced by heating tumors for 15, 30 or 60 min via a custom-designed HT probe placed superficially at the tumor location. In vivo fluorescence imaging (excitation 523 nm, emission 610 nm) was performed before, during, and for 5 min following HT. After imaging, tumors were extracted, drug uptake was quantified by high-performance liquid chromatography, and correlated with in vivo fluorescence. Plasma samples were obtained before and after HT to measure TSL-Dox pharmacokinetics. Results: Local drug uptake could be visualized in real-time during HT. Compared to unheated control tumors, fluorescence of heated tumors increased by 4.6-fold (15 min HT), 9.3-fold (30 min HT), and 13.2-fold (60 min HT). HT duration predicted tumor drug uptake (p = .02), with tumor drug concentrations of 4.2 ± 1.3 µg/g (no HT), 7.1 ± 5.9 µg/g (15 min HT), 14.1 ± 6.7 µg/g (30 min HT) and 21.4 ± 12.6 µg/g (60 min HT). There was good correlation (R2 = 0.67) between fluorescence of the tumor region and tumor drug uptake. Conclusions: Real-time in vivo fluorescence imaging can visualize drug uptake during delivery, and can predict tumor drug uptake.
Entities:
Keywords:
Hyperthermia; cancer; chemotherapy; drug delivery systems; liposomes; thermosensitive liposomes
Authors: Ann L B Seynhaeve; Bilyana M Dicheva; Saske Hoving; Gerben A Koning; Timo L M Ten Hagen Journal: J Control Release Date: 2013-09-04 Impact factor: 9.776
Authors: Miles A Miller; Bjorn Askevold; Katherine S Yang; Rainer H Kohler; Ralph Weissleder Journal: ChemMedChem Date: 2014-02-06 Impact factor: 3.466
Authors: Linus Willerding; Simone Limmer; Martin Hossann; Anja Zengerle; Kirsten Wachholz; Timo L M Ten Hagen; Gerben A Koning; Ronald Sroka; Lars H Lindner; Michael Peller Journal: J Control Release Date: 2015-12-03 Impact factor: 9.776
Authors: Li Li; Timo L M ten Hagen; Azadeh Haeri; Thomas Soullié; Csilla Scholten; Ann L B Seynhaeve; Alexander M M Eggermont; Gerben A Koning Journal: J Control Release Date: 2013-11-22 Impact factor: 9.776
Authors: Astrid Gasselhuber; Matthew R Dreher; Frank Rattay; Bradford J Wood; Dieter Haemmerich Journal: PLoS One Date: 2012-10-17 Impact factor: 3.240
Authors: Krishna K Ramajayam; A Marissa Wolfe; Anjan Motamarry; Georges J Nahhas; John Yost; Michael J Yost; Dieter Haemmerich Journal: IEEE Open J Eng Med Biol Date: 2021-05-11
Authors: Patrick M Perrigue; Richard A Murray; Angelika Mielcarek; Agata Henschke; Sergio E Moya Journal: Pharmaceutics Date: 2021-05-21 Impact factor: 6.321